Delivery Order SPE2DB20D1100-SPE2DB25FE5Q3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,131.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Lisinopril 40 mg, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct fulfillment order under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of 1,000 tablets of Lisinopril-HCTZ 20-25 mg at a ceiling value of $1,344.35. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract has an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4,563,955,470 tablets of 10 mg Lisinopril, a common blood pressure medication, to support military treatment programs and facilities. The delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of the medication Lisinopril 40 mg tablets. The contract has a firm fixed price of $1,053.60 and a completion date of May 6, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999.00,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,110,689 lisinopril 20 mg tablets in lots of 1,000. This $1,056.28 award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract with DLA to deliver pharmaceutical products and medical...
- This federal contract award, valued at $1,266.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB22D1041|SPE2DB25FUAP8) for the supply of 4,568,175,234 tablets of the drug Lisinopril 10 mg. The contract has an ultimate completion date of May 8, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $9,085.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of 4,565,079,360 tablets of Lisinopril 10 mg, a common cardiovascular medication. The contract has an ultimate completion date of July 8, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,402.88, is for the delivery of 1,000 tablets of 40 milligram Lisinopril, a medication used to treat high blood pressure and other cardiovascular conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $47,100 to Amerisourcebergen Drug Corporation for 1,000 tablets of the pharmaceutical lisinopril. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by July 27, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for the blood pressure medication lisinopril is consistent with the Defense Logistics Agency's mission to...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at thirteen thousand one hundred twenty dollars to Amerisourcebergen Drug Corporation for one thousand tablets of the pharmaceutical lisinopril, a drug used to treat high blood pressure. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the lisinopril tablets to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania between August 10-11, 2023. The Defense Logistics Agency,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE5Q3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of 1,000 tablets of Lisinopril 10 mg, valued at $1,563.72. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively bid. The contract is scheduled for ultimate completion on September 10, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Lisinopril is an ACE inhibitor commonly used to treat hypertension and heart failure, making this a routine pharmaceutical procurement for military and federal healthcare needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's role as a major pharmaceutical distributor and critical vendor for federal medical procurement reflects its established capability to meet federal requirements through open competition and its established relationships with the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/9/25 |